[1]
S. Hotte, T. Waldron, C. Canil, and E. Winquist, “Interleukin-2 in the treatment of unresectable or metastatic renal cell cancer: a systematic review and practice guideline”, CUAJ, vol. 1, no. 1, Dec. 2012.